Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes, according to a study presented at ENDO 2025, the Endocrine…
Category: 5. Health
-
How 17M Americans enrolled in Medicaid and ACA plans could lose their health insurance by 2034
The big tax and spending package President Donald Trump signed into law on July 4, 2025, will cut government spending on health care by more than US$1 trillion over the next decade.
Because the final version of the legislation moved swiftly…
Continue Reading
-
Semaglutide melts fat—but may quietly strip away your strength
Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small study presented at ENDO 2025, the Endocrine…
Continue Reading
-
OpenEvidence Cofounder Daniel Nadler Is Now A Billionaire.
Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 million at a $3.5 billion valuation.
For doctors trying to stay abreast of the latest medical breakthroughs, reviewing the…
Continue Reading
-
Doctors Think AI Shows Promise—But Worry It Will Mislead Patients
getty
For over a decade now, healthcare workers have had to deal with “Doctor Google”—when patients turn to Google for medical advice instead of a professional. It’s a practice that organizations including Brown University Health, Orlando…
Continue Reading
-
Extroverted People More Likely To Enjoy High-Intensity Aerobic Exercises: Study
Enorm in Form, Aerobic Sendung, Deutschland 1983, Vorturngruppe um Judith Jagiello und Gaby Just. … More
Are you struggling to stay physically…
Continue Reading
-
Weight-loss wonder drug Mounjaro/Zepbound shrinks breast cancer tumors
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study presented at ENDO 2025, the Endocrine Society’s annual…
Continue Reading
-
Obesity is driving a hidden cancer epidemic—13 types and rising deaths nationwide
Cancer deaths linked to obesity have tripled in the United States over the past two decades, according to a study being presented at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
The study, which examined more than…
Continue Reading
-
Sweet but risky: Common sweeteners may be accelerating puberty in kids
Consuming certain sweeteners commonly found in foods and beverages may increase the risk of early puberty in children, particularly among those who are genetically predisposed, according to a study presented at ENDO 2025, the Endocrine Society’s…
Continue Reading
-
One shot, seven days: Long-acting levodopa gel tackles Parkinson’s tremors
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson’s disease, potentially replacing the need for multiple daily tablets.
Scientists from the University of South Australia (UniSA) have…
Continue Reading